Skip to content
10-Q

Quarterly Report

STARTEK, INC.

0001437749-23-014026

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 40.32M sh
Shares Diluted Q1 2023 · Mar 31, 2023 40.32M sh
Shares Diluted Q1 2023 · Mar 31, 2022 40.34M sh
Stock Repurchased Q1 2023 · Mar 31, 2023 $0
Stock Repurchased Q1 2023 · Mar 31, 2022 $1.27M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$3.91M
Operating Cash Flow restated Q1 2023 · Mar 31, 2022 $1.51M
Long Term Debt Q1 2023 · Mar 31, 2023 $66.94M
Long Term Debt Q1 2023 · Dec 31, 2022 $41.18M
Short Term Debt Q1 2023 · Mar 31, 2023 $14.88M
Short Term Debt Q1 2023 · Dec 31, 2022 $14.27M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $15.77M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $22.46M
Cash And Equivalents restated Q1 2023 · Mar 31, 2022 $25.83M
Stockholders Equity Q1 2023 · Mar 31, 2023 $187.91M
Stockholders Equity Q1 2023 · Dec 31, 2022 $187.77M
Current Liabilities Q1 2023 · Mar 31, 2023 $221.36M
Current Liabilities Q1 2023 · Dec 31, 2022 $288.46M
Total Liabilities Q1 2023 · Mar 31, 2023 $334.45M
Total Liabilities Q1 2023 · Dec 31, 2022 $374.48M
Current Assets Q1 2023 · Mar 31, 2023 $319.9M
Current Assets Q1 2023 · Dec 31, 2022 $355.74M
Total Assets Q1 2023 · Mar 31, 2023 $589.35M
Total Assets Q1 2023 · Dec 31, 2022 $626.04M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.01
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.03
Eps Basic Q1 2023 · Mar 31, 2023 −$0.01
Eps Basic Q1 2023 · Mar 31, 2022 −$0.03
Sga Expense Q1 2023 · Mar 31, 2023 $10.29M
Sga Expense restated Q1 2023 · Mar 31, 2022 $11.96M
Net Income Q1 2023 · Mar 31, 2023 −$670K
Net Income Q1 2023 · Mar 31, 2022 −$1.24M
Operating Income Q1 2023 · Mar 31, 2023 $2.36M
Operating Income restated Q1 2023 · Mar 31, 2022 $1.83M
Gross Profit Q1 2023 · Mar 31, 2023 $12.96M
Gross Profit restated Q1 2023 · Mar 31, 2022 $13.79M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $79.13M
Cost Of Revenue restated Q1 2023 · Mar 31, 2022 $87.3M